Yep, Vaxinia kicked off ages ago. What trial updates are you expecting? Because currently Vaxinia has only elicited 1 CR from 38 patients (who was in the initial lowest dose cohort). That's what I'd call an outlier.
"A CN at 3.8c is smart"
You think IMU will reacquire these convertible notes at a premium, and that this is "smart"?
Surely, if Hopper was actually expecting results contrary to what has been published to date, he would have taken some of the ~$37m he made back in 2021 and redeployed it in IMU for the upside? At 3.8c, all he would need is $2.85m to recover the 75m heads he sold at >1,000% premium.
(20min delay)